This opportunity has expired. It is therefore no longer possible to like or apply.
See similar opportunities insteadYour career starts on Magnet.me
Create a profile and receive smart job recommendations based on your liked jobs.
About the programme
If you share our passion for science and technology, and want to make a genuine difference to the lives of patients, today and in the future, then the PT&D graduate programme was made for you. The programme is all about looking forward, using ground breaking science and technology to meet the needs of patients.
We can't develop the kind of incredible medicines we do, without developing people first. And to do that, we have an incredible culture of support and collaboration, as well as the tools, rewards and opportunities you need to take your scientific career further. As a graduate, you'll be working on a variety of projects, with some of the world's most experienced scientists. So every day will be an opportunity to learn and grow, and enjoy making your talent count.
What does the programme involve?
The two-year programme starts in September 2018 and includes three distinct rotations through different areas of PT&D. These will provide you with broad exposure to multiple areas of basic and applied scientific research, and experience of the medicines design, development and commercialisation process through the application of science on development projects. You can choose from a wide range of placements and we'll do all we can to meet your preferences.
You'll also complete our global graduate development programme. Three times over the two years, you'll be part of a graduate cohort that comes together in one of our global locations to develop the leadership and self-management skills required for success. You can expect a competitive salary and benefits, potential for future employment and mentor support from the outset.
Essential requirements
What we're looking for:
AstraZeneca is a global, science-led biopharmaceutical company that spans the discovery, development, manufacturing, distribution and worldwide commercialisation of primary care and speciality care medicines.
Change language to: Dutch
This page is optimised for people from the Netherlands. View the version optimised for people from the UK.